Bing Center for Waldenstrom's Macroglobulinemia

You are here: Home

Latest Bing Center News

Bing Center Posters Presented at IWWM-10

The 10th International Workshop on Waldenstrom's Macroglobulinemia was held October 11-13, 2018 in New York City, USA. The following are the 8 posters presented by the Bing Center for Waldenstrom's Macroglobulinemia.

A Patient's Legacy Gift

“Dana-Farber has given me a second life,” says Lu Kleppinger, who was treated for a rare blood cancer. “We wanted to make the largest impact possible. What greater gift can we give than one to save lives?” Lu and her husband, Tony, wanted to support the research that saved Lu’s life, so they decided to include Dana-Farber in their estate plans as they prepare for retirement. “It’s the ultimate gift,” continues Lu.

23rd Annual EHA Meeting - Bing Center Poster Presentations

The 23rd Annual European Hematology Association Congress was held was held June 14-17, 2018 in Stockholm Sweden. The following are the posters presented by the Bing Center for Waldenstrom's Macroglobulinemia.

Steven Treon Interview - April 21, 2018, Milan, Italy

Interview with Dr. Steven Treon in Milan Italy, April 21, 2018 on new research and treatments for Waldenstrom's Macroglobulinemia.

Dr. Treon Addresses delegates at EMN and WM patients in Northern Italy

Over 800 delegates were present at the First European Myeloma Network Meeting, that took place in Torino, Italy under the auspices of Mario Boccadoro of the University of Torino on April 19-21, 2018.

Dr. Zachary Hunter Draws a Crowd in Northern VA/Washington, DC!

Dr. Zachary Hunter, Ph.D. in Pathology and Director of Genomics at the Bing Center for Waldenström’s Macroglobulinemia drew a crowd of over 60 WMers and caregivers for his presentation “Personalized Medicine in Waldenström’s Macroglobulinemia: What It Means and How We Make It Happen” on April 21, 2018, one of our largest number of guests in the four years since the inception of our IWMF Support Group in 2014.

US FDA Approves New Imbruvica/Ibrutinib Formulation

On February 16, 2018, Imbruvica (ibrutinib) was approved by the US FDA in multiple strengths as a 140, 280, 420, and 460 mg tablet. The new formulations are now commercially available, and the original 140 mg capsule will no longer be available after May 15, 2018. Please see the full Prescribing Information (link is external) for indications, dosage and usage.

Online WM Workshop - Progress in the Treatment of WM

On Wednesday, June 27th, 2018 from 1:30PM – 2:30PM EST, Dr. Jorge Castillo of Dana-Farber Cancer Institute and Dr. Morie Gertz of Mayo Clinic will engage in a discussion on “Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM).” The program is free, but you must register to participate. https://www.iwmf.com/news-and-events/news/sign-free-iwmf-cancercare-onlinephone-wm-workshop-0

5th International Patient and Physician Summit on WM

Dear Friends: It is with great pleasure to invite you to the 5th International Patient and Physician Summit on Waldenstrom’s Macroglobulinemia (WM). The Summit will take place on October 13-14, 2018, at the New York Marriott Downtown Hotel and Conference Center, situated in Lower Manhattan next to the Freedom Tower.